Table 2. Comparison of characteristics between MDR and XDR prevalence in Chinese Han population.
| Characteristics | No. (%) isolates | OR* (95%CI) | |||||
| non-MDR | MDR/XDR | non-XDR MDR | XDR | MDR/XDR vs. non-MDR | XDR vs. non-XDR MDR | XDR vs. non-MDR | |
| Sex | |||||||
| Male | 503(88.1) | 68(11.9) | 63(92.6) | 5(7.4) | reference | reference | reference |
| Female | 302(86.5) | 47(13.5) | 41(87.2) | 6(12.8) | 1.16(0.77–1.74) | 1.97(0.54–7.23) | 1.96(0.58–6.55) |
| Age group | |||||||
| <20 | 53(86.9) | 8(13.1) | 8(100) | 0(0.0) | 0.66(0.29–1.50) | - | - |
| 20–29 | 183(92.0) | 16(8.0) | 15(93.8) | 1(6.3) | 0.40(0.21–0.73) | 0.37(0.04–3.56) | 0.24(0.03–2.07) |
| 30–39 | 128(88.9) | 16(11.1) | 15(93.8) | 1(6.3) | 0.57(0.30–1.05) | 0.45(0.05–4.20) | 0.30(0.03–2.53) |
| 40–49 | 147(90.2) | 16(9.8) | 14(87.5) | 2(12.5) | 0.50(0.27–0.92) | 0.95(0.17–5.42) | 0.56(0.11–2.87) |
| 50–59 | 83(84.7) | 15(15.3) | 14(93.3) | 1(6.7) | 0.86(0.45–1.64) | 0.48(0.05–4.45) | 0.48(0.06–4.09) |
| ≥60 | 211(82.7) | 44(17.3) | 38(86.4) | 6(13.6) | reference | reference | reference |
| Patients type | |||||||
| Inpatients | 668(87.2) | 98(12.8) | 90(91.8) | 8(8.2) | reference | reference | reference |
| Outpatients | 137(89.0) | 17(11.0) | 14(82.4) | 3(17.6) | 0.68(0.38–1.23) | 1.72(0.38–7.78) | 1.03(0.24–4.37) |
| TB treatment | |||||||
| New | 346(87.6) | 49(12.4) | 46(93.9) | 3(6.1) | reference | reference | reference |
| Retreatment | 459(87.4) | 66(12.6) | 58(87.9) | 8(12.1) | 1.03(0.68–1.56) | 1.70(0.41–7.13) | 1.82(0.45–7.40) |
CI, confidence interval; MDR, multidrug resistance; MDR/XDR, MDR TB and XDR TB; non-XDR MDR, MDR without XDR; OR, odds ratio; XDR, extensively drug resistance; Boldface indicates significance.
*
Adjusted for the characteristics for which adjusted ORs are shown.